MPM (MALLEABLE PROTEIN MATRIX) POUR SON UTILISITATION DANS LE TRAITEMENT DE L'ARTHRITE, L'OBESITE, LA RÉSISTANCE À L'INSULINE, LE DIABETE DE TYPE 2, LES MALADIES AUTOIMMUNES, L'HYPERTENSION ET L'HYPERLIPIDEMIE
It is disclosed a method of immunomodulating an immune response in a subject comprising administering to a subject a malleable protein matrix (MPM), from fermented whey, in an amount effective to modulate the biological activity of Th17 cells, and its associated metabolic pathway, for a preventative or a therapeutic purpose of a variety of health applications in the field of immunity or obesity related diseases.